In contrast, other studies showed that ROR2 inhibited proliferation in gastric [26], colorectal [23], and ovarian cancer [41], as well as in esophageal squamous cell carcinoma [42]. The gene discussed is ROR2; the disease is esophageal squamous cell carcinoma.